Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-κB and upregulation of BCL-2 and BCL-XL

Oncogene

Volumn 25, Issue 22, 2006, Pages 3160-3169

  Konishi, T ^a   Sasaki, S ^a   Watanabe, T ^a   Kitayama, J ^a   Nagawa, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

5 FU; Apoptosis; Bcl 2 family; Colorectal cancer; hRFI; NF B

Indexed keywords

BETA GALACTOSIDASE; FLUOROURACIL; HUMAN RING FINGER HOMOLOGOUS TO INHIBITOR OF APOPTOSIS PROTEIN TYPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; COLORECTAL CANCER; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BCL-X PROTEIN; CARRIER PROTEINS; COLORECTAL NEOPLASMS; CYTOCHROMES C; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HCT116 CELLS; HUMANS; MITOCHONDRIA; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 33745102414     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209342     Document Type: Article

References (50)

1. Baeuerle PA, Henkel T. (1994). Annu Rev Immunol 12: 141-179.
2. Baldwin Jr AS. (1996). Annu Rev Immunol 14: 649-683.
3. Beinke S, Ley SC. (2004). Biochem J 382: 393-409.
4. Bharti AC, Aggarwal BB. (2002). Biochem Pharmacol 64: 883-888.
5. Catz SD, Johnson JL. (2001). Oncogens 20: 7342-7351.
6. Cory S, Adams JM. (2002). Nat Rev Cancer 2: 647-656.
7. Cusack Jr JC, Liu R, Baldwin Jr AS. (2000). Cancer Res 60: 2323-2330.
8. Fesik SW. (2000). Cell 103: 273-282.
9. Ghosh S, May MJ, Kopp EB. (1998). Annu Rev Immunol 16: 225-260.
10. Green DR, Reed JC. (1998). Science 281: 1309-1312.
11. Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Tanighchi T. (1994). Mol Cell Biol 4: 1500-1509.
12. Holcik M, Gibson H, Korneluk RG. (2001). Apoptosis 6: 253-261.
13. Huang DC, Strasser A. (2000). Cell 103: 839-842.
14. Huang H, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD, Hunter T. (2000). J Biol Chem 275: 26661-26664.
15. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP et al. (2001). Nat Med 7: 1111-1117.
16. Kahlenberg MS, Sullivan JM, Witmer DD, Petrelli NJ. (2003). Surg Oncol 12: 173-186.
17. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. (1997). Science 275: 1132-1136.
18. Konishi T, Sasaki S, Watanabe T, Kitayama J, Nagawa H. (2005). Mol Cancer Ther 4: 743-750.
19. Korsmeyer SJ. (1992). Blood 80: 879-886.
20. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. (1997). Cell 91: 479-489.
21. MacFarlane M, Merrison W, Bratton SB, Cohen GM. (2002). J Biol Chem 277: 36611-36616.
22. Martinou JC, Desagher S, Antonsson B. (2000). Nat Cell Biol 2: E41-E43.
23. Maurer CA, Friess H, Buhler SS, Wahl BR, Graber H, Zimmermann A et al. (1998). Dig Dis Sci 43: 2641-2648.
24. Miyashita T, Reed JC. (1993). Blood 81: 151-157.
25. Mori N, Fujii M, Cheng G, Ikeda S, Yamasaki Y, Yamada Y et al. (2001). Virus Genes 22: 279-287.
26. Nita ME, Nagawa H, Tominaga O, Tsuno N, Fujii S, Sasaki S et al. (1998). Br J Cancer 78: 986-992.
27. Nita ME, Ono-Nita SK, Tsuno N, Tominaga O, Takenoue T, Sunami E et al. (2000). Jpn J Cancer Res 91: 825-832.
28. Ogura E, Senzaki H, Yamamoto D, Yoshida R, Takada H, Hioki K et al. (1999). Oncol Rep 6: 365-369.
29. Pahl HL. (1999). Oncogene 18: 6853-6866.
30. Panwalkar A, Verstovsek S, Giles F. (2004). Cancer 100: 1578-1589.
31. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T et al. (1997). J Biol Chem 272: 21096-21103.
32. Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S et al. (1996). J Cell Biochem 60: 23-32.
33. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M et al. (2001). Nucleic Acids Res 29: E21.
34. Rigas A, Dervenis C, Giannakou N, Kozoni V, Shiff SJ, Rigas B. (2002). Cancer Invest 20: 657-665.
35. Sasaki S, Kitayama J, Watanabe T, Konishi T, Nagawa H. (2004a). Jpn J Clin Oncol 34: 584-587.
36. Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H et al. (2002). Oncogene 21: 5024-5030.
37. Sasaki S, Watanabe T, Konishi T, Kitayama J, Nagawa H. (2004b). J Exp Clin Cancer Res 23: 507-512.
38. Sasaki S, Watanabe T, Konishi T, Nagawa H. (2003). Nippon Rinsho 61(Suppl 7): 242-246.
39. Sevilla L, Zaldumbide A, Pognonec P, Boulukos KE. (2001). Histol Histopathol 16: 595-601.
40. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. (2002). Cancer Res 62: 6323-6328.
41. Syken J, De-Medina T, Munger K. (1999). Proc Natl Acad Sci USA 96: 8499-8504.
42. Syken J, Macian F, Agarwal S, Rao A, Munger K. (2003). Oncogene 22: 4636-4641,
43. Tsujimoto Y. (2000). J Neural Transm Suppl 58: 41-52.
44. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J et al. (2002). Int J Cancer 98: 498-504.
45. Voboril R, Hochwald SN, Li J, Brank A, Weberova J, Wessels F et al. (2004). J Surg Res 120: 178-188.
46. Wang W, Cassidy J. (2003). Br J Cancer 88: 624-629.
47. Wang W, McLeod HL, Cassidy J. (2003). Int J Cancer 104: 504-511.
48. Yang L, Cao Z, Yan H, Wood WC. (2003). Cancer Res 63: 6815-6824.
49. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. (2000). Science 288: 874-877.
50. Yang Y, Yu X. (2003). FASEB J 17: 790-799.